ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:ABL • US0028241000
91.55 EUR
-1.7 (-1.82%)
Last: Feb 3, 2026, 05:04 PM
ABL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. While ABL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ABL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year ABL was profitable.
- ABL had a positive operating cash flow in the past year.
- In the past 5 years ABL has always been profitable.
- ABL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- ABL's Return On Assets of 16.60% is amongst the best of the industry. ABL outperforms 95.59% of its industry peers.
- ABL has a better Return On Equity (27.43%) than 97.06% of its industry peers.
- With a decent Return On Invested Capital value of 8.88%, ABL is doing good in the industry, outperforming 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ABL has a Profit Margin of 31.88%. This is amongst the best in the industry. ABL outperforms 100.00% of its industry peers.
- ABL's Profit Margin has improved in the last couple of years.
- ABL has a better Operating Margin (18.29%) than 75.00% of its industry peers.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- ABL has a Gross Margin (56.19%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABL is destroying value.
- There is no outstanding debt for ABL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- ABL has an Altman-Z score of 5.26. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 5.26, ABL belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
- ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
- ABL's Debt to FCF ratio of 1.87 is amongst the best of the industry. ABL outperforms 82.35% of its industry peers.
- ABL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- ABL has a better Debt to Equity ratio (0.23) than 72.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.26 |
ROIC/WACC0.88
WACC10.04%
2.3 Liquidity
- A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
- ABL has a Current ratio (1.70) which is in line with its industry peers.
- ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Quick ratio of 1.24. This is comparable to the rest of the industry: ABL outperforms 55.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
- The Revenue has been growing slightly by 5.67% in the past year.
- Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.18% yearly.
- The Revenue is expected to grow by 7.15% on average over the next years.
EPS Next Y11.35%
EPS Next 2Y10.76%
EPS Next 3Y9.84%
EPS Next 5Y10.18%
Revenue Next Year7.19%
Revenue Next 2Y7.26%
Revenue Next 3Y7.21%
Revenue Next 5Y7.15%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 21.05, which indicates a rather expensive current valuation of ABL.
- Compared to the rest of the industry, the Price/Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 72.06% of the companies listed in the same industry.
- ABL is valuated rather cheaply when we compare the Price/Earnings ratio to 28.41, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 18.90 indicates a rather expensive valuation of ABL.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 60.29% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (25.64), we can say ABL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.05 | ||
| Fwd PE | 18.9 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABL is on the same level as its industry peers.
- ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 60.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.25 | ||
| EV/EBITDA | 17.66 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
- ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.85
PEG (5Y)2.95
EPS Next 2Y10.76%
EPS Next 3Y9.84%
5. Dividend
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.38%.
- ABL's Dividend Yield is rather good when compared to the industry average which is at 1.03. ABL pays more dividend than 80.88% of the companies in the same industry.
- ABL's Dividend Yield is a higher than the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- 28.93% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
- The dividend of ABL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y9.84%
FRA:ABL (2/3/2026, 5:04:14 PM)
91.55
-1.7 (-1.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap159.19B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts79.43
Price Target125.19 (36.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
Yearly Dividend1.86
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)0.53%
PT rev (3m)-1.07%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.71%
Revenue NY rev (3m)-0.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.05 | ||
| Fwd PE | 18.9 | ||
| P/S | 4.3 | ||
| P/FCF | 27.25 | ||
| P/OCF | 20.67 | ||
| P/B | 3.7 | ||
| P/tB | 8.81 | ||
| EV/EBITDA | 17.66 |
EPS(TTM)4.35
EY4.75%
EPS(NY)4.84
Fwd EY5.29%
FCF(TTM)3.36
FCFY3.67%
OCF(TTM)4.43
OCFY4.84%
SpS21.3
BVpS24.75
TBVpS10.39
PEG (NY)1.85
PEG (5Y)2.95
Graham Number49.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.26 |
F-Score8
WACC10.04%
ROIC/WACC0.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.35%
EPS Next 2Y10.76%
EPS Next 3Y9.84%
EPS Next 5Y10.18%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7.19%
Revenue Next 2Y7.26%
Revenue Next 3Y7.21%
Revenue Next 5Y7.15%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y14.39%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.05 and the Price/Book (PB) ratio is 3.7.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.